Paid Clinical Trials in Valhalla, NY

As of September 2026, 97 paid clinical trials are recruiting in Valhalla, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

85 clinical trials

Get a weekly email when new trials open in Valhalla, NY.

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

for B-cell Lymphoma

Drug: Polatuzumab Vedotin

1 location in Valhalla

Sponsor: New York Medical College

Sex: All·Age: 12 - 70

Code: NCT04491370·Phase 1, Phase 2·Recruiting·Listed Jul 2020

Apply to this trial

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

for CMV

Sites in Valhalla +1 more location

Sponsor: New York Medical College

Sex: All·Age: 1 Day - 30

Code: NCT07225972·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

for Systemic Lupus Erythematosus

Sites in Valhalla, The Bronx +18 more locations

Sponsor: AstraZeneca

Sex: All·Age: 5 - 17

Code: NCT05835310·Phase 3·Recruiting·Listed Apr 2023

Apply to this trial

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

for Thrombotic Microangiopathies

Sites in Valhalla, New York +6 more locations

Sponsor: Omeros Corporation

Sex: All·Age: 28 Days - 17

Code: NCT05855083·Phase 2·Recruiting·Listed May 2023

Apply to this trial